Damase-Michel C, Tavernier G, Giraud P, Montastruc J L, Montastruc P, Tran M A
Laboratoire de Pharmacologie Médicale et Clinique, INSERM U317, Faculté de Médecine, Toulouse, France.
Naunyn Schmiedebergs Arch Pharmacol. 1993 Oct;348(4):379-84. doi: 10.1007/BF00171337.
Various neuropeptides are costored together with catecholamines in the adrenal medulla. The concurrent release (evaluated by adrenal vein plasma levels) of these neuropeptides [neuropeptide Y (NPY), met-enkephaline (ME)] and catecholamines [adrenaline (A) and noradrenaline (NA)] from the adrenal gland was examined in chloralose-anesthetized dogs after intravenous administration of clonidine (10 micrograms/kg) and dihydralazine (1 mg/kg). These results were compared to those obtained after the stimulation of the right splanchnic nerve at 1, 5 and 10 Hz frequencies. The increment in the release of catecholamines and neuropeptides was evaluated for dihydralazine and splanchnic nerve stimulation. Dihydralazine (at its maximal effect) induced a significant preferential increase in catecholamines (expressed as mean (SEM): NA: 17.3 (5.4) fold, A: 13.1 (2.6) fold) and ME (16.0 (7.1) fold) versus basal values. However, the significant increase in NPY-LI was only 2.0 (0.4) times the baseline. Splanchnic nerve stimulation induced a frequency-dependent increase in catecholamines and neuropeptides. When the stimulation frequency was increased from 1 Hz to 5 Hz, NA and A levels increased 17.9 (4.3) and 14.0 (2.2) fold, respectively and ME levels 14.1 (3.0) fold. By contrast, NPY-LI was increased only 2.3 (0.3) fold under the same conditions. Increasing the stimulation frequency from 5 Hz to 10 Hz resulted in similar elevations of NA, ME, and NPY-LI adrenal plasma levels (about 4 times) whereas A only increased twice. Clonidine decreased catecholamine and ME adrenal plasma levels (the maximal percent decrease when compared with control values was about 75%) whereas NPY adrenal plasma levels remained unchanged.(ABSTRACT TRUNCATED AT 250 WORDS)
多种神经肽与儿茶酚胺共同储存于肾上腺髓质中。在水合氯醛麻醉的犬静脉注射可乐定(10微克/千克)和双肼屈嗪(1毫克/千克)后,检测了这些神经肽[神经肽Y(NPY)、甲硫氨酸脑啡肽(ME)]和儿茶酚胺[肾上腺素(A)和去甲肾上腺素(NA)]从肾上腺的同时释放情况(通过肾上腺静脉血浆水平评估)。将这些结果与在1、5和10赫兹频率刺激右侧内脏神经后获得的结果进行比较。评估了双肼屈嗪和内脏神经刺激导致的儿茶酚胺和神经肽释放增加情况。双肼屈嗪(在其最大效应时)导致儿茶酚胺[表示为平均值(标准误):NA:17.3(5.4)倍,A:13.1(2.6)倍]和ME(16.0(7.1)倍)相对于基础值有显著的优先增加。然而,NPY-LI的显著增加仅为基线的2.0(0.4)倍。内脏神经刺激导致儿茶酚胺和神经肽呈频率依赖性增加。当刺激频率从1赫兹增加到5赫兹时,NA和A水平分别增加17.9(4.3)倍和14.0(2.2)倍,ME水平增加14.1(3.0)倍。相比之下,在相同条件下NPY-LI仅增加2.3(0.3)倍。将刺激频率从5赫兹增加到10赫兹导致NA(去甲肾上腺素)、ME和NPY-LI肾上腺血浆水平有相似的升高(约4倍),而A仅增加两倍。可乐定降低了儿茶酚胺和ME肾上腺血浆水平(与对照值相比最大百分比降低约75%),而NPY肾上腺血浆水平保持不变。(摘要截断于250字)